Circulating renin-angiotensin system and catecholamines in childhood: Is there a role for birthweight?

Clinical Science

Volumn 114, Issue 5-6, 2008, Pages 375-380

  Franco, Maria C P ^a   Casarini, Dulce E ^a   Carneiro Ramos, Marcela S ^b   Sawaya, Ana L ^a   Barreto Chaves, Maria L M ^b   Sesso, Ricardo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; Angiotensin converting enzyme (ACE) activity; Birthweight; Blood pressure; Noradrenaline; Small for gestational age

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; NORADRENALIN;

ADOLESCENT; ADRENERGIC SYSTEM; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE MEASUREMENT; CATECHOLAMINE BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCHOOL CHILD; BLOOD; BLOOD PRESSURE; CHILD; CROSS-SECTIONAL STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; NEWBORN; PHYSIOLOGY; SMALL FOR DATE INFANT;

ADOLESCENT; ANGIOTENSIN II; BIRTH WEIGHT; BLOOD PRESSURE; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; NOREPINEPHRINE; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM;

EID: 39549119811     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070284     Document Type: Article

References (33)

1. Barker, D. J., Gluckman, P. D., Godfrey, K. M., Harding, J. E., Owens, J. A. and Robinson, J. S. (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341, 938-941
2. Barker, D. J. (1990) The fetal origins of type 2 diabetes mellitus. Ann. Intern. Med. 130, 322-324
3. Barker, D. J. (2006) Commentary: birthweight and coronary heart disease in a historical cohort. Int. J. Epidemiol. 35, 886-897
4. Franco, M. C., Christofalo, D. M., Sawaya, A. L., Ajzen, S. A. and Sesso, R. (2006) Effects of low birth weight in 8-to 13-year-old children: implications in endothelial function and uric acid levels. Hypertension 48, 45-50
5. Franco, M. C., Kawamoto, E. M., Gorjão, R. et al. (2007) Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation. Pediatr. Res. 62, 204-208
6. Franco, M. C., Higa, E. M., D'Almeida, V. et al. (2007) Homocysteine and nitric oxide are related to blood pressure and vascular function in small-for-gestational-age children. Hypertension 50, 396-402
7. Galland, B. C., Taylor, B. J., Bolton, D. P. and Sayers, R. M. (2006) Heart rate variability and cardiac reflexes in small for gestational age infants. J. Appl. Physiol. 100, 933-939
8. Johansson, S., Norman, M., Legnevall, L., Dalmaz, Y., Lagercrantz, H. and Vanpée, M. (2007) Increased catecholamines and heart rate in children with low birth weight: perinatal contributions to sympathoadrenal overactivity. J. Intern. Med. 261, 480-487
9. Boguszewski, M. C., Johannsson, G., Fortes, L. C. and Sverrisdóttir, Y. B. (2004) Low birth size and final height predict high sympathetic nerve activity in adulthood. J. Hypertens. 22, 1157-1163
10. Zhang, X. Q., Varner, M., Dizon-Townson, D., Song, F. and Ward, K. (2003) A molecular variant of angiotensinogen is associated with idiopathic intrauterine growth restriction. Obstet. Gynecol. 101, 237-242
11. Miyawaki, M., Okutani, T., Higuchi, R. and Yoshikawa, N. (2006) Plasma angiotensin II concentrations in the early neonatal period. Arch. Dis. Child. Fetal Neonatal Ed. 91, F359-F362
12. Forsyth, J. S., Reilly, J., Fraser, C. G. and Struthers, A. D. (2004) Angiotensin converting enzyme activity in infancy is related to birth weight. Arch. Dis. Child. Fetal Neonatal Ed. 89, F442-F444
13. Perondi, R., Saino, A. and Tio, R. A. (1992) ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation 85, 2004-2013
14. Santos, R. A., Krieger, E. M. and Greene, L. J. (1985) An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension 7, 244-252
15. Naffah-Mazzacoratti, M. G., Casarini, D. E., Fernandes, M. J. S. and Cavalheiro, E. A. (1992) Serum catecholamine levels determined by high performance liquid chromatography coupled with electrochemical detection. Arq. Bras. Endocrinol. Metab. 36, 119-122
16. Kim, S. and Iwao, H. (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 52, 11-34
17. Anderson, E. A., Sinkey, C. A., Lawton, W. J. and Mark, A. L. (1989) Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 14, 177-173
18. Eriksson, U., Danilczyk, U. and Penninger, J. M. (2002) Just the beginning: novel functions for angiotensin-converting enzymes. Curr. Biol. 12, 745-752
19. Carey, R. M. and Siragy, H. M. (2003) Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 24, 261-271
20. Cesari, M., Rossi, G. P. and Pessina, A. C. (2002) Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J. Hypertens. 20, 793-799
21. Riviere, G., Michaud, A., Breton, C. et al. (2005) Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. Hypertension 46, 1169-1174
22. McMullen, S., Gardner, D. S. and Langley-Evans, S. C. (2004) Prenatal programming of angiotensin II type 2 receptor expression in the rat. Br. J. Nutr. 91, 133-140
23. Ceravolo, G. S., Franco, M. C., Carneiro-Ramos, M. S. and Carvalho, M. H. C. (2007) Enalapril and losartan restored blood pressure and vascular reactivity in intrauterine undernourished rats. Life Sci. 80, 782-787
24. Wintour, E. M., Johnson, K., Koukoulas, I., Moritz, K., Tersteeg, M. and Dodic, M. (2003) Programming the cardiovascular system, kidney and the brain: a review. Placenta 24, S65-S71
25. Cambien, F., Leger, J., Mallet, C., Levy-Marchal, C., Collin, D. and Czernichow, P. (1998) Angiotensin I-converting enzyme gene polymorphism modulates the consequences of in utero growth retardation on plasma insulin in young adults. Diabetes 47, 470-475
26. Kajantie, E., Rautanen, A. and Kere, J. (2004) The effects of the ACE gene insertion/deletion polymorphism on glucose tolerance and insulin secretion in elderly people are modified by birth weight. J. Clin. Endocrinol. Metab. 89, 5738-5741
27. Akisu, M., Balim, Z., Cetin, H. et al. (2004) The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intrauterine growth restriction. Early Hum. Dev. 78, 95-103
28. Sata, F., Yamada, H., Suzuki, K. et al. (2006) Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction. Pharmacogenet. Genomics 16, 775-781
29. Thapar, A., Langley, K. and Fowler, T. (2005) Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 62, 1275-1278
30. Cox, S. L., Trendelenburg, A. U. and Starke, K. (1999) Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br. J. Pharmacol. 127, 1256-1262
31. Lyons, D., Jackson, S. H. and Swift, C. G. (2007) Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man. Clin. Pharmacol. Ther. 81, 83-87
32. Watson, A. M., Hood, S. G. and May, C. N. (2006) Mechanisms of sympathetic activation in heart failure. Clin. Exp. Pharmacol. Physiol. 33, 1269-1274
33. Schlaich, M. P., Lambert, E. and Kaye, D. M. (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43, 169-175